Islet Sciences
Raleigh · Founded 1994
About Islet Sciences
Islet Sciences is in the process of developing its first product, Islet Sciences-P™ ’ a vialed suspension of microencapsulated porcine islets for injection into the abdominal cavity. Islet Sciences-P will be a ready-to-use formulation that will require very little preparation by the transplant surgeon. Islet Sciences' technologies are designed to improve microencapsulated islet cell viability and functionality at several points in the preparation of this suspension. We believe our cell handling techniques substantially increase the longevity and functionality of the encapsulated islet cells.
Company Facts
- Founded: 1994
- Operating status: Closed
- Company type: For Profit
- IPO status: Delisted
- Employees: 11 – 50
- Total funding: $695.0K
- Funding stage: IPO
- Last round: Post-IPO Equity (Feb 2014)
- Website: isletsciences.com
- Phone: 919.480.1518
Social Profiles
Canonical: https://fsome.com/organization/islet-sciences-8442399 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.